These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 33191781)
1. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus. Willeford A; Zhu W; Stevens C; Thomas IC Ann Pharmacother; 2021 Jul; 55(7):839-845. PubMed ID: 33191781 [TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus. Bass ME; Kiser TH; Page RL; McIlvennan CK; Allen LA; Wright G; Shakowski C J Thromb Thrombolysis; 2021 Aug; 52(2):517-522. PubMed ID: 33420896 [TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus. Herald J; Goitia J; Duan L; Chen A; Lee MS Am J Cardiovasc Drugs; 2022 Jul; 22(4):437-444. PubMed ID: 35352321 [TBL] [Abstract][Full Text] [Related]
4. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials. Sahlén AO; Jiang H; Lau YH; Cuenza L; Cader FA; Al-Omary M; Surunchupakorn P; Ho KH; Sung J; Lee D; Honda S; Tan Wei Chieh J; Yap J J Clin Pharmacol; 2023 Oct; 63(10):1101-1107. PubMed ID: 37139934 [TBL] [Abstract][Full Text] [Related]
5. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
6. Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡. Alcalai R; Butnaru A; Moravsky G; Yagel O; Rashad R; Ibrahimli M; Planer D; Amir O; Elbaz-Greener G; Leibowitz D Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):660-667. PubMed ID: 34279598 [TBL] [Abstract][Full Text] [Related]
7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795 [TBL] [Abstract][Full Text] [Related]
8. Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya. Varwani MH; Shah J; Ngunga M; Jeilan M Pan Afr Med J; 2021; 39():212. PubMed ID: 34630824 [TBL] [Abstract][Full Text] [Related]
9. Reduced-Dose Apixaban in the Treatment of Left Ventricular Thrombus: A Report of 2 Cases. Bundrick AE; Bowers RD; Perkins SL; Baker CN J Pharm Pract; 2024 Apr; 37(2):517-521. PubMed ID: 36475939 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients. Kalani C; Awudi E; Alexander T; Udeani G; Surani S Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732 [No Abstract] [Full Text] [Related]
11. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis. See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254 [TBL] [Abstract][Full Text] [Related]
12. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin. Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654 [TBL] [Abstract][Full Text] [Related]
13. Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study. Coons EM; Staubes BA; Casey AL; Elagizi-Youssef SA; Mohammed AE; Sharma N; Kline ER Ann Pharmacother; 2022 May; 56(5):533-540. PubMed ID: 34470525 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study. Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A; CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273 [TBL] [Abstract][Full Text] [Related]
15. Comparing Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Extreme Obesity. Lorenz MA; Linneman TW J Pharm Pract; 2023 Dec; 36(6):1375-1382. PubMed ID: 35938580 [No Abstract] [Full Text] [Related]
16. Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials. Chen Y; Zhu M; Wang K; Xu Q; Ma J J Cardiovasc Pharmacol; 2022 Jun; 79(6):935-940. PubMed ID: 35383658 [TBL] [Abstract][Full Text] [Related]
17. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses. Iskaros O; Marsh K; Papadopoulos J; Manmadhan A; Ahuja T J Cardiovasc Pharmacol; 2021 May; 77(5):621-631. PubMed ID: 33560043 [TBL] [Abstract][Full Text] [Related]
19. Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. Robinson AA; Trankle CR; Eubanks G; Schumann C; Thompson P; Wallace RL; Gottiparthi S; Ruth B; Kramer CM; Salerno M; Bilchick KC; Deen C; Kontos MC; Dent J JAMA Cardiol; 2020 Jun; 5(6):685-692. PubMed ID: 32320043 [TBL] [Abstract][Full Text] [Related]
20. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP; Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]